SixPack-AbScan: a web server to discover cross-reactivity of antibodies across species
SixPack-AbScan is a free, species-agnostic web server that aids researchers working with non-model organisms in identifying potential antibody cross-reactivity by computationally screening for epitope sequence conservation, thereby prioritizing candidates for experimental validation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In the vast landscape of biological research, scientists rely on specialized tools to see the invisible machinery of life. Among the most essential of these tools are antibodies, Y-shaped proteins that act like highly specific molecular hooks. Researchers use them to latch onto particular proteins inside cells, allowing them to visualize where those proteins are located or to measure how much of them exists. For decades, this technology has been perfected for a small group of "model" organisms, such as humans, mice, and fruit flies, which serve as the standard laboratories for understanding biology. However, the natural world is filled with millions of other species, from deep-sea creatures to rare insects, that scientists wish to study but for whom these molecular hooks do not exist.
When a researcher wants to study a non-model organism, they face a difficult choice. They can spend years and significant money to create a new antibody from scratch, a process that is slow and expensive. Alternatively, they can try to use an antibody designed for a mouse or a human, hoping it will accidentally stick to the protein in their new species. This second approach, known as cross-reactivity, is a common gamble. It often involves testing hundreds of different commercial antibodies on tissue samples, a trial-and-error process that can take months and yield very little. The core challenge is knowing which antibody to pick before the experiment even begins, without having to test every single one physically.
A new digital tool called SixPack-AbScan offers a way to make this gamble more informed. Developed by Marco Grillo at the Science for Life Laboratory in Stockholm, this free web server acts as a computational filter that helps researchers predict whether an antibody designed for one species might work on another. Instead of guessing, the software looks at the specific "address" on a protein that an antibody recognizes, known as an epitope. It then scans the genetic blueprint of the target organism to see if that exact address exists there. If the sequence is found, the tool flags the antibody as a strong candidate for experimental testing. This approach does not guarantee success, but it allows scientists to prioritize the most promising reagents and skip the ones that are mathematically unlikely to work.
The tool operates on a straightforward principle: if an antibody binds to a specific string of amino acids in a mouse, and that same string of amino acids appears in the protein of a non-model organism, the antibody might bind there too. The software takes a list of these known binding strings from commercial antibody catalogs and compares them against the genetic data of the organism in question. This genetic data can come in two forms. If the researcher has a list of known proteins, the software checks those directly. If they only have the raw genetic code, the tool performs a "six-frame translation." This process reads the genetic code in all possible directions and starting points, converting it into potential protein sequences. While this method generates many theoretical strings that do not actually exist in nature, the tool relies on the fact that a specific, complex string of ten to twenty amino acids is extremely unlikely to appear by pure chance in a random sequence.
The interface is designed to be accessible to scientists who may not be experts in computer programming. Users simply upload a table of antibody information, which includes the specific protein sequences the antibodies are known to bind, and a file containing the genetic or protein data of their target species. The system then processes this information and returns a list of matches. If a match is found, the output tells the researcher exactly which antibody product corresponds to the hit and which protein in the new species contains the matching sequence. This allows the researcher to see if the antibody might bind to a single unique protein or if it might accidentally stick to several similar ones, which would make the experimental results confusing.
The developers are careful to define the limits of what this tool can do. It is a pre-screening mechanism, not a final answer. The software only looks for exact matches of continuous, linear sequences. It does not account for how proteins fold into complex 3D shapes, whether the binding site is hidden inside the cell, or if chemical modifications might block the antibody. It also does not predict how strongly the antibody will bind. Because of these limitations, a positive result from the server is not a promise that the experiment will work, but rather a signal that the experiment is worth trying. Conversely, a negative result does not mean the antibody will fail, as the tool cannot detect subtle changes in the sequence that might still allow binding.
This approach fills a specific gap for researchers working on the edges of biological knowledge. For those studying organisms that have never been the focus of major commercial antibody development, the tool provides a way to leverage the massive investment already made in model organisms. By using the tool, a scientist can take a catalog of thousands of available antibodies and narrow them down to a manageable handful of candidates to test in the lab. The tool is currently available online without registration, and the code behind it is open for others to examine and improve. It represents a practical shift from blind experimentation to data-driven selection, helping researchers navigate the vast diversity of life with a bit more certainty and a lot less wasted effort.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.